SCHEMBL3567162

SCHEMBL3567162

CN(C)N=C1C=CC(NC(=O)C(c2cccs2)N(C(N)=O)c2ccc(Cl)cc2)C=C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
LMNA P02545 3/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
POLB P06746 3/20 0.35
ALOX5 P09917 1/20 0.33
GPX4 P36969 3/20 0.33
NPC1 O15118 1/20 0.33
YAP1 P46937 1/20 0.33
RAB9A P51151 1/20 0.33
PAX8 Q06710 1/20 0.33
TEAD4 Q15561 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PIK3C3 Q8NEB9 1/20 0.33
PRNP P04156 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3559263 0.85 ALDH1A1 (0.35) ALDH1A1GAASMN1; SMN2
SCHEMBL3562891 0.84 ALDH1A1 (0.39) MAPTALDH1A1KDM4ELMNAGAA
SCHEMBL3564955 0.84 ALDH1A1 (0.39) MAPTALDH1A1KDM4ELMNAGAA
SCHEMBL3566488 0.83 MDM2 (0.31) KMT2A
SCHEMBL3560346 0.83 MEN1 (0.33) LMNAGAASMN1; SMN2MEN1KMT2A
SCHEMBL3564406 0.82
SCHEMBL3573280 0.82 CNR2 (0.32) MAPTMEN1KMT2A
SCHEMBL3564557 0.82
SCHEMBL3564974 0.81 LPAR1 (0.34) MAPTLMNAGAASMN1; SMN2MEN1
SCHEMBL3570078 0.74 TRPM8 (0.34) ALDH1A1KDM4EGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678913-B2 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2010-03-16 US claimed
US-20060160821-A1 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US claimed
US-7678913-B2 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2010-03-16 US disclosed
US-20060160821-A1 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US disclosed
WO-2006063113-A2 UREAS AS FACTOR XA INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160821-A1 Ureas as factor Xa inhibitors TFPI, F12, F11 MAPT 1933/4885ALDH1A1 1143/4885KDM4E 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.